Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 7 sources · 2 days · First seen · Last updated
HIV research and treatment developments
Overview
Recent scientific studies have highlighted both potential breakthroughs and ongoing challenges in HIV management. Researchers at the University of California, Davis, have developed an experimental bispecific antibody that targets the CCR5 receptor and the CD3 protein on T lymphocytes. In trials involving rhesus macaques infected with simian immunodeficiency virus (SIV), a relative of HIV, this antibody helped prevent viral recurrence in some subjects; notably, one subject remained undetectable for four years following treatment.
However, other research indicates complexities in long-term management. Studies from Radboudumc in the Netherlands suggest that suppressing viral replication through antiretroviral therapy does not always ensure full immune system recovery. Findings show significant variations in immunological responses and biological aging markers among patients, which may increase vulnerability to age-related diseases despite effective viral suppression.
Entities
University of California, Davis · Dennis Hartigan-O'Connor · Jesse Deere · The Lancet HIV · Nature Microbiology
Timeline
-
[HEALTH] 3 sourcesResearchers investigate HIV treatment efficacy and immune recovery
Studies reveal a potential HIV breakthrough using bispecific antibodies in primate trials, while Dutch research shows immune recovery varies significantly among patients despite effective viral suppression.
-
[HEALTH] 4 sourcesExperimental antibody prevents HIV-like virus return in monkey study
An experimental antibody has kept an HIV-like virus undetectable in a monkey for four years, while new data from South Africa suggests HIV prevention progress has plateaued since 2019.
Sources
conowego.pl · geekweek.interia.pl · groundup.org.za · n1info.rs · naukawpolsce.pap.pl · sciencealert.com · xconomy.com